Tuesday, March 1, 2016

It just follows therefore

It Just follow therefore that IDH-1 would be a Biomarker for use of
Temodar and 5-AZAcitadine or Decitabine for Gliobastoma
and may be adding Ifosfamide or Etoposide for Leukemia and sarcoma (Chondrosarcoma) that is positive for Mutant IDH-1.    (and wild type TET)
Post a Comment